Clinical Trial Update: A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 study of everolimus, trastuzumab, and vinorelbine in HER2-positive breast cancer with brain metastases has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)
• Trastuzumab (trastuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: HER-2 Positive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-10-17